Patexia Research

Case number 2:22-cv-02952

Lawsuits

CELGENE CORPORATION v. ONCOGEN PHARMA (MALAYSIA) SDN. BHD. > Summary

Court Case Number 2:22-cv-02952

Filing Date May 20, 2022

Termination Date May 25, 2022

Court New Jersey District Court

Status Dismissed - Other

JudgesSusan D. Wigenton, Leda D. Wettre

Plaintiff

Defendant

2

Plaintiff Attorneys

Celgene
Attorney Name: Charles M. Lizza
Saul Ewing LLP

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
09101621	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation	Aug 11, 2015
09101622	Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone	Aug 11, 2015
08648095	Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor	Feb 11, 2014
08530498	Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione	Sep 10, 2013
07968569	Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione	Jun 28, 2011
07855217	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 21, 2010
07465800	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione	Dec 16, 2008